The role of α-synuclein, the major amyloid component of Lewy bodies, in dysregulating Lrrk2 is of particular interest for understanding dementia, which occurs in a significant number of PD patients who have triplication of the α-synuclein gene [225]. Here, LRRK2 is linked to Parkinson disease.